£600K
The funding round was backed by the Midlands Engine Investment Fund, Mercia Ventures, and Pioneer Group.
I
ImmuONE
ImmuONE develops human lung tissue models to replace animal testing in drug safety evaluations.
United Kingdom—Founded 2019
£2.6MTotal raised
ImmuONE is a British biotech startup that develops advanced human lung models for preclinical safety testing. The company provides animal-free alternatives for evaluating drugs, chemicals, and consumer products.
Categories
Team
AM
Abigail Martin
Co-founder
VH
Victoria Hutter
Professor
Investors
- £600K
- £2.0M
Funding history
£2.0M
The funding will support new laboratories in Stevenage and headquarters in Milton Keynes alongside team expansion.